{
    "xml": "<topic id=\"PHP4656\" outputclass=\"drug\" rev=\"1.17\" type=\"drug\" namespace=\"/drugs/alendronic-acid\" basename=\"alendronic-acid\" title=\"ALENDRONIC ACID\">\n<title>ALENDRONIC ACID</title>\n<body>\r\n<p outputclass=\"interactionsLinks\"> List of individual interactants: <xref format=\"dita\" href=\"#bnf_int_459\" namespace=\"/interactions/list-of-drug-interactions/bisphosphonates/alendronic-acid\">Alendronic Acid</xref>\n</p>\n<data name=\"vtmid\">421552005</data>\n<data name=\"classifications\">\n<data name=\"classification\">\n<data name=\"drugClassification\">\n<xref format=\"dita\" scope=\"local\" type=\"drugClassification\" href=\"#_819087817\" title=\"Bisphosphonates\">Bisphosphonates</xref>\n</data>\n<data name=\"inheritsFromClass\">\n<xref format=\"dita\" scope=\"local\" type=\"drugClass\" href=\"#PHP34620\" title=\"BISPHOSPHONATES\" namespace=\"/drug-classes/bisphosphonates\">BISPHOSPHONATES</xref>\n</data>\n</data>\n</data>\n<data name=\"primaryDomainOfEffect\">\n<data name=\"domainOfEffect\">  </data>\n</data>\r\n<p outputclass=\"synonyms\">Alendronate</p>\r\n</body>\n<topic id=\"PHP69534\" outputclass=\"indicationsAndDose\" rev=\"1.21\" parent=\"/drugs/alendronic-acid\">\n<title>Indications and dose</title>\n<body>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Treatment of postmenopausal osteoporosis</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By mouth</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult female\">\n<p>Adult (female)</p>\n<p>10&#8239;mg daily, alternatively 70&#8239;mg once weekly.</p>\n</li>\n</ul>\n</section>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Treatment of osteoporosis in men</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By mouth</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult male\">\n<p>Adult (male)</p>\n<p>10&#8239;mg daily.</p>\n</li>\n</ul>\n</section>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Prevention and treatment of corticosteroid-induced osteoporosis in postmenopausal women not receiving hormone replacement therapy</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By mouth</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult female\">\n<p>Adult (female)</p>\n<p>10&#8239;mg daily.</p>\n</li>\n</ul>\n</section>\n</body>\n</topic>\n<topic id=\"PHP69598\" outputclass=\"contraindications\" rev=\"1.7\" parent=\"/drugs/alendronic-acid\">\n<title>Contra-indications</title>\n<body>\n<section outputclass=\"contraindications\">\n<p>\n<ph outputclass=\"contraindication\">Abnormalities of oesophagus</ph>; <ph outputclass=\"contraindication\">hypocalcaemia</ph>; <ph outputclass=\"contraindication\">other factors which delay emptying (e.g. stricture or achalasia)</ph>\n</p>\n</section>\n</body>\n</topic>\n<topic id=\"PHP69608\" outputclass=\"cautions\" rev=\"1.7\" parent=\"/drugs/alendronic-acid\">\n<title>Cautions</title>\n<body>\n<section outputclass=\"cautions\">\n<p>\n<ph outputclass=\"caution\">Active gastro-intestinal bleeding</ph>; <ph outputclass=\"caution\">atypical femoral fractures</ph>; <ph outputclass=\"caution\">duodenitis</ph>; <ph outputclass=\"caution\">dysphagia</ph>; <ph outputclass=\"caution\">exclude other causes of osteoporosis</ph>; <ph outputclass=\"caution\">gastritis</ph>; <ph outputclass=\"caution\">history (within 1 year) of ulcers</ph>; <ph outputclass=\"caution\">surgery of the upper gastro-intestinal tract</ph>; <ph outputclass=\"caution\">symptomatic oesophageal disease</ph>; <ph outputclass=\"caution\">ulcers</ph>; <ph outputclass=\"caution\">upper gastro-intestinal disorders</ph>\n</p>\n</section>\n</body>\n</topic>\n<topic id=\"PHP69530\" outputclass=\"interactions\" rev=\"1.6\" parent=\"/drugs/alendronic-acid\">\n<title>Interactions</title>\n<body>\n<section outputclass=\"general\">\n<sectiondiv>\n<p>Appendix 1 (bisphosphonates).</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP69450\" outputclass=\"sideEffects\" rev=\"1.21\" parent=\"/drugs/alendronic-acid\">\n<title>Side-effects</title>\n<body>\n<section outputclass=\"generalSideEffects\">\n<sectiondiv outputclass=\"frequencies\">\n<sectiondiv outputclass=\"commonOrVeryCommon\">\n<p outputclass=\"title\">Common or very common</p>\n<p outputclass=\"sideEffects\">\n<ph outputclass=\"sideEffect\">Abdominal distension</ph>; <ph outputclass=\"sideEffect\">abdominal pain</ph>; <ph outputclass=\"sideEffect\">alopecia</ph>; <ph outputclass=\"sideEffect\">asthenia</ph>; <ph outputclass=\"sideEffect\">constipation</ph>; <ph outputclass=\"sideEffect\">diarrhoea</ph>; <ph outputclass=\"sideEffect\">dizziness</ph>; <ph outputclass=\"sideEffect\">dyspepsia</ph>; <ph outputclass=\"sideEffect\">flatulence</ph>; <ph outputclass=\"sideEffect\">headache</ph>; <ph outputclass=\"sideEffect\">joint swelling</ph>; <ph outputclass=\"sideEffect\">musculoskeletal pain</ph>; <ph outputclass=\"sideEffect\">oesophageal reactions</ph>; <ph outputclass=\"sideEffect\">peripheral oedema</ph>; <ph outputclass=\"sideEffect\">pruritus</ph>; <ph outputclass=\"sideEffect\">regurgitation</ph>; <ph outputclass=\"sideEffect\">vertigo</ph>\n</p>\n</sectiondiv>\n<sectiondiv outputclass=\"uncommon\">\n<p outputclass=\"title\">Uncommon</p>\n<p outputclass=\"sideEffects\">\n<ph outputclass=\"sideEffect\">Dysgeusia</ph>; <ph outputclass=\"sideEffect\">episcleritis</ph>; <ph outputclass=\"sideEffect\">erythema</ph>; <ph outputclass=\"sideEffect\">gastritis</ph>; <ph outputclass=\"sideEffect\">malaise (on initiation)</ph>; <ph outputclass=\"sideEffect\">melena</ph>; <ph outputclass=\"sideEffect\">myalgia (on initiation)</ph>; <ph outputclass=\"sideEffect\">nausea</ph>; <ph outputclass=\"sideEffect\">rash</ph>; <ph outputclass=\"sideEffect\">scleritis</ph>; <ph outputclass=\"sideEffect\">uveitis</ph>; <ph outputclass=\"sideEffect\">vomiting</ph>\n</p>\n</sectiondiv>\n<sectiondiv outputclass=\"rare\">\n<p outputclass=\"title\">Rare</p>\n<p outputclass=\"sideEffects\">\n<ph outputclass=\"sideEffect\">Atypical femoral fractures with long-term use</ph>; <ph outputclass=\"sideEffect\">fever (on initiation)</ph>; <ph outputclass=\"sideEffect\">hypocalcaemia</ph>; <ph outputclass=\"sideEffect\">osteonecrosis of the jaw</ph>; <ph outputclass=\"sideEffect\">photosensitivity</ph>; <ph outputclass=\"sideEffect\">severe skin reactions</ph>; <ph outputclass=\"sideEffect\">Stevens-Johnson syndrome</ph>; <ph outputclass=\"sideEffect\">toxic epidermal necrolysis</ph>\n</p>\n</sectiondiv>\n</sectiondiv>\n</section>\n<section outputclass=\"sideEffectsAdvice\">\n<title>Side-effects, further information</title>\n<sectiondiv>\n<p outputclass=\"title\">Oesophageal reactions</p>\n<p>Severe oesophageal reactions (oesophagitis, oesophageal ulcers, oesophageal stricture and oesophageal erosions) have been reported; patients should be advised to stop taking the tablets and to seek medical attention if they develop symptoms of oesophageal irritation such as dysphagia, new or worsening heartburn, pain on swallowing or retrosternal pain.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP69517\" outputclass=\"pregnancy\" parent=\"/drugs/alendronic-acid\">\n<title>Pregnancy</title>\n<body>\n<section outputclass=\"generalInformation\">\n<sectiondiv>\n<p>Avoid.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP69614\" outputclass=\"breastFeeding\" parent=\"/drugs/alendronic-acid\">\n<title>Breast feeding</title>\n<body>\n<section outputclass=\"generalInformation\">\n<sectiondiv>\n<p>Manufacturer advises avoid&#8212;no information available.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP69483\" outputclass=\"renalImpairment\" parent=\"/drugs/alendronic-acid\">\n<title>Renal impairment</title>\n<body>\n<section outputclass=\"generalInformation\">\n<sectiondiv>\n<p>Avoid if eGFR less than 35&#8239;mL/minute/1.73&#8239;m<sup>2</sup>.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP69400\" outputclass=\"monitoringRequirements\" parent=\"/drugs/alendronic-acid\">\n<title>Monitoring requirements</title>\n<body>\n<section outputclass=\"monitoringOfPatientParameters\">\n<sectiondiv>\n<p>Correct disturbances of calcium and mineral metabolism (e.g. vitamin-D deficiency, hypocalcaemia) before starting treatment. Monitor serum-calcium concentration during treatment.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP69638\" outputclass=\"directionsForAdministration\" rev=\"1.10\" parent=\"/drugs/alendronic-acid\">\n<title>Directions for administration</title>\n<body>\n<section>\n<sectiondiv>\n<p>Tablets should be swallowed whole and oral solution should be swallowed as a single 100&#8239;mL dose. Doses should be taken with plenty of water while sitting or standing, on an empty stomach at least 30 minutes before breakfast (or another oral medicine); patient should stand or sit upright for at least 30 minutes after administration.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP69499\" outputclass=\"patientAndCarerAdvice\" rev=\"1.19\" parent=\"/drugs/alendronic-acid\">\n<title>Patient and carer advice</title>\n<body>\n<section outputclass=\"generalPatientAdvice\">\n<sectiondiv>\n<p>Patients or their carers should be given advice on how to administer alendronic acid tablets and oral solution.</p>\n</sectiondiv>\n<sectiondiv>\n<p outputclass=\"title\">Oesophageal reactions</p>\n<p>Patients (or their carers) should be advised to stop taking alendronic acid and to seek medical attention if they develop symptoms of oesophageal irritation such as dysphagia, new or worsening heartburn, pain on swallowing or retrosternal pain.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP69367\" outputclass=\"nationalFunding\" rev=\"1.39\" parent=\"/drugs/alendronic-acid\">\n<title>National funding/access decisions</title>\n<body>\r\n<section>\r\n<sectiondiv outputclass=\"niceTechnologyAppraisals\">\r\n<p outputclass=\"title\">NICE technology appraisals (TAs)</p>\r\n<sectiondiv outputclass=\"niceTechnologyAppraisal\">\r\n<p outputclass=\"fundingIdentifier\">NICE TA160</p>\r\n<sectiondiv>\r\n<p outputclass=\"title\">Alendronate, etidronate, risedronate, raloxifene and strontium ranelate for the primary prevention of osteoporotic fragility fractures in postmenopausal women (October 2008)</p>\r\n<p>\r\n<b>Alendronate</b> is recommended as a treatment option for the primary prevention of osteoporotic fractures in the following susceptible postmenopausal women:</p>\r\n<ul>\r\n<li>Women over 70 years who have an independent risk factor for fracture (parental history of hip fracture, alcohol intake of 4 or more units per day, or rheumatoid arthritis) <i>or</i> an indicator of low bone mineral density (body mass index under 22&#8239;kg/m<sup>2</sup>, ankylosing spondylitis, Crohn&#8217;s disease, prolonged immobility, untreated premature menopause, or rheumatoid arthritis) <b>and</b> confirmed osteoporosis.</li>\r\n<li>Women aged 65&#8211;69 years who have an independent risk factor for fracture and confirmed osteoporosis.</li>\r\n<li>Women under 65 years who have an independent risk factor for fracture and at least one additional indicator of low bone mineral density and confirmed osteoporosis.</li>\r\n</ul>\n</sectiondiv>\n<xref format=\"html\" href=\"http://www.nice.org.uk/TA160\">www.nice.org.uk/TA160</xref>\n</sectiondiv>\r\n<sectiondiv outputclass=\"niceTechnologyAppraisal\">\r\n<p outputclass=\"fundingIdentifier\">NICE TA161</p>\r\n<sectiondiv>\r\n<p outputclass=\"title\">Alendronate, etidronate, risedronate, raloxifene, strontium ranelate, and teriparatide for the secondary prevention of osteoporotic fragility fractures in postmenopausal women (October 2008)</p>\r\n<p>This guideline recommends treatment options for the secondary prevention of osteoporotic fractures in postmenopausal women with confirmed osteoporosis who have also sustained a clinically apparent osteoporotic fracture.</p>\r\n<p>\r\n<b>Alendronate</b> is recommended as a treatment option for the secondary prevention of osteoporotic fractures in susceptible postmenupausal women.</p>\n</sectiondiv>\n<xref format=\"html\" href=\"http://www.nice.org.uk/TA161\">www.nice.org.uk/TA161</xref>\n</sectiondiv>\n</sectiondiv>\r\n </section>\r\n\r\n</body>\n</topic>\n<topic id=\"PHP4656-medicinalForms\" outputclass=\"medicinalForms\" parent=\"/drugs/alendronic-acid\">\n<title>Medicinal forms</title>\n<body>\n<section outputclass=\"licensingVariationStatement\">\n<p>There can be variation in the licensing of different medicines containing the same drug.</p>\n</section>\n<p>Forms available from special-order manufacturers include: oral solution</p>\n</body>\n</topic>\n<parents>\n<xref format=\"dita\" scope=\"local\" type=\"drugs\" href=\"#drugs\" title=\"Drugs\" namespace=\"/drugs\">Drugs</xref>\n</parents>\n<children>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP75004\" title=\"Tablet\" namespace=\"/drugs/alendronic-acid/tablet\">Tablet</xref>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP75020\" title=\"Oral solution\" namespace=\"/drugs/alendronic-acid/oral-solution\">Oral solution</xref>\n</children>\n<backlinks>\n<xref format=\"dita\" scope=\"local\" type=\"drug\" href=\"#PHP85566\" namespace=\"/drugs/alendronic-acid-with-colecalciferol\" title=\"ALENDRONIC ACID WITH COLECALCIFEROL\" count=\"1\" rel=\"backlink\">ALENDRONIC ACID WITH COLECALCIFEROL</xref>\n<xref format=\"dita\" scope=\"local\" type=\"drugClassifications\" href=\"#PHP106980\" namespace=\"/drug-classifications\" title=\"Drug classifications\" count=\"1\" rel=\"backlink\">Drug classifications</xref>\n<xref format=\"dita\" scope=\"local\" type=\"treatmentSummary\" href=\"#PHP78314\" namespace=\"/treatment-summaries/bone-metabolism\" title=\"Bone metabolism\" count=\"1\" rel=\"backlink\">Bone metabolism</xref>\n</backlinks>\n<links>\n<xref format=\"dita\" scope=\"local\" type=\"interaction\" href=\"#bnf_int_459\" namespace=\"/interactions/list-of-drug-interactions/bisphosphonates/alendronic-acid\" title=\"Alendronic Acid\" count=\"1\" rel=\"link\">Alendronic Acid</xref>\n<xref format=\"dita\" scope=\"local\" type=\"drugClass\" href=\"#PHP34620\" namespace=\"/drug-classes/bisphosphonates\" title=\"BISPHOSPHONATES\" count=\"1\" rel=\"link\">BISPHOSPHONATES</xref>\n<xref format=\"dita\" scope=\"local\" type=\"#drugs\" href=\"#drugs\" namespace=\"/drugs\" title=\"Drugs\" count=\"1\" rel=\"link\">Drugs</xref>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP75004\" namespace=\"/drugs/alendronic-acid/tablet\" title=\"Tablet\" count=\"1\" rel=\"link\">Tablet</xref>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP75020\" namespace=\"/drugs/alendronic-acid/oral-solution\" title=\"Oral solution\" count=\"1\" rel=\"link\">Oral solution</xref>\n</links>\n</topic>",
    "id": "PHP4656",
    "outputclass": "drug",
    "rev": "1.17",
    "type": "drug",
    "namespace": "/drugs/alendronic-acid",
    "basename": "alendronic-acid",
    "title": "ALENDRONIC ACID",
    "interactants": [
        {
            "id": "bnf_int_459",
            "label": "Alendronic Acid"
        }
    ],
    "vtmid": "421552005",
    "drugClassification": [
        "Bisphosphonates"
    ],
    "inheritsFromClass": [
        "BISPHOSPHONATES"
    ],
    "primaryDomainOfEffect": {
        "": {
            "domain": "",
            "therapeuticUses": {}
        }
    },
    "synonyms": [
        "Alendronate"
    ],
    "indicationsAndDoses": {
        "indicationAndDoseGroups": [
            {
                "indications": [
                    {
                        "textContent": "Treatment of postmenopausal osteoporosis",
                        "html": "Treatment of postmenopausal osteoporosis"
                    }
                ],
                "specificity": {
                    "routes": [
                        "mouth"
                    ],
                    "textContent": "By mouth",
                    "html": "By mouth"
                },
                "adult female": [
                    {
                        "textContent": "10 mg daily, alternatively 70 mg once weekly.",
                        "html": "<p>10&#8239;mg daily, alternatively 70&#8239;mg once weekly.</p>",
                        "ageGroup": "adult (female)"
                    }
                ]
            },
            {
                "indications": [
                    {
                        "textContent": "Treatment of osteoporosis in men",
                        "html": "Treatment of osteoporosis in men"
                    }
                ],
                "specificity": {
                    "routes": [
                        "mouth"
                    ],
                    "textContent": "By mouth",
                    "html": "By mouth"
                },
                "adult male": [
                    {
                        "textContent": "10 mg daily.",
                        "html": "<p>10&#8239;mg daily.</p>",
                        "ageGroup": "adult (male)"
                    }
                ]
            },
            {
                "indications": [
                    {
                        "textContent": "Prevention and treatment of corticosteroid-induced osteoporosis in postmenopausal women not receiving hormone replacement therapy",
                        "html": "Prevention and treatment of corticosteroid-induced osteoporosis in postmenopausal women not receiving hormone replacement therapy"
                    }
                ],
                "specificity": {
                    "routes": [
                        "mouth"
                    ],
                    "textContent": "By mouth",
                    "html": "By mouth"
                },
                "adult female": [
                    {
                        "textContent": "10 mg daily.",
                        "html": "<p>10&#8239;mg daily.</p>",
                        "ageGroup": "adult (female)"
                    }
                ]
            }
        ]
    },
    "contraindications": {
        "contraindications": [
            {
                "type": "contraindications",
                "textContent": "Abnormalities of oesophagus",
                "html": "Abnormalities of oesophagus"
            },
            {
                "type": "contraindications",
                "textContent": "hypocalcaemia",
                "html": "hypocalcaemia"
            },
            {
                "type": "contraindications",
                "textContent": "other factors which delay emptying (e.g. stricture or achalasia)",
                "html": "other factors which delay emptying (e.g. stricture or achalasia)"
            }
        ]
    },
    "cautions": {
        "cautions": [
            {
                "type": "cautions",
                "textContent": "Active gastro-intestinal bleeding",
                "html": "Active gastro-intestinal bleeding"
            },
            {
                "type": "cautions",
                "textContent": "atypical femoral fractures",
                "html": "atypical femoral fractures"
            },
            {
                "type": "cautions",
                "textContent": "duodenitis",
                "html": "duodenitis"
            },
            {
                "type": "cautions",
                "textContent": "dysphagia",
                "html": "dysphagia"
            },
            {
                "type": "cautions",
                "textContent": "exclude other causes of osteoporosis",
                "html": "exclude other causes of osteoporosis"
            },
            {
                "type": "cautions",
                "textContent": "gastritis",
                "html": "gastritis"
            },
            {
                "type": "cautions",
                "textContent": "history (within 1 year) of ulcers",
                "html": "history (within 1 year) of ulcers"
            },
            {
                "type": "cautions",
                "textContent": "surgery of the upper gastro-intestinal tract",
                "html": "surgery of the upper gastro-intestinal tract"
            },
            {
                "type": "cautions",
                "textContent": "symptomatic oesophageal disease",
                "html": "symptomatic oesophageal disease"
            },
            {
                "type": "cautions",
                "textContent": "ulcers",
                "html": "ulcers"
            },
            {
                "type": "cautions",
                "textContent": "upper gastro-intestinal disorders",
                "html": "upper gastro-intestinal disorders"
            }
        ]
    },
    "interactions": {
        "general": [
            {
                "type": "general",
                "textContent": "Appendix 1 (bisphosphonates).",
                "html": "<p>Appendix 1 (bisphosphonates).</p>"
            }
        ]
    },
    "sideEffects": {
        "general": {
            "frequencies": {
                "commonOrVeryCommon": [
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "Abdominal distension",
                        "html": "Abdominal distension",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "abdominal pain",
                        "html": "abdominal pain",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "alopecia",
                        "html": "alopecia",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "asthenia",
                        "html": "asthenia",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "constipation",
                        "html": "constipation",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "diarrhoea",
                        "html": "diarrhoea",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "dizziness",
                        "html": "dizziness",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "dyspepsia",
                        "html": "dyspepsia",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "flatulence",
                        "html": "flatulence",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "headache",
                        "html": "headache",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "joint swelling",
                        "html": "joint swelling",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "musculoskeletal pain",
                        "html": "musculoskeletal pain",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "oesophageal reactions",
                        "html": "oesophageal reactions",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "peripheral oedema",
                        "html": "peripheral oedema",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "pruritus",
                        "html": "pruritus",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "regurgitation",
                        "html": "regurgitation",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "vertigo",
                        "html": "vertigo",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    }
                ],
                "uncommon": [
                    {
                        "type": "uncommon",
                        "textContent": "Dysgeusia",
                        "html": "Dysgeusia",
                        "frequency": "uncommon",
                        "specificity": {
                            "textContent": "Uncommon",
                            "html": "Uncommon"
                        }
                    },
                    {
                        "type": "uncommon",
                        "textContent": "episcleritis",
                        "html": "episcleritis",
                        "frequency": "uncommon",
                        "specificity": {
                            "textContent": "Uncommon",
                            "html": "Uncommon"
                        }
                    },
                    {
                        "type": "uncommon",
                        "textContent": "erythema",
                        "html": "erythema",
                        "frequency": "uncommon",
                        "specificity": {
                            "textContent": "Uncommon",
                            "html": "Uncommon"
                        }
                    },
                    {
                        "type": "uncommon",
                        "textContent": "gastritis",
                        "html": "gastritis",
                        "frequency": "uncommon",
                        "specificity": {
                            "textContent": "Uncommon",
                            "html": "Uncommon"
                        }
                    },
                    {
                        "type": "uncommon",
                        "textContent": "malaise (on initiation)",
                        "html": "malaise (on initiation)",
                        "frequency": "uncommon",
                        "specificity": {
                            "textContent": "Uncommon",
                            "html": "Uncommon"
                        }
                    },
                    {
                        "type": "uncommon",
                        "textContent": "melena",
                        "html": "melena",
                        "frequency": "uncommon",
                        "specificity": {
                            "textContent": "Uncommon",
                            "html": "Uncommon"
                        }
                    },
                    {
                        "type": "uncommon",
                        "textContent": "myalgia (on initiation)",
                        "html": "myalgia (on initiation)",
                        "frequency": "uncommon",
                        "specificity": {
                            "textContent": "Uncommon",
                            "html": "Uncommon"
                        }
                    },
                    {
                        "type": "uncommon",
                        "textContent": "nausea",
                        "html": "nausea",
                        "frequency": "uncommon",
                        "specificity": {
                            "textContent": "Uncommon",
                            "html": "Uncommon"
                        }
                    },
                    {
                        "type": "uncommon",
                        "textContent": "rash",
                        "html": "rash",
                        "frequency": "uncommon",
                        "specificity": {
                            "textContent": "Uncommon",
                            "html": "Uncommon"
                        }
                    },
                    {
                        "type": "uncommon",
                        "textContent": "scleritis",
                        "html": "scleritis",
                        "frequency": "uncommon",
                        "specificity": {
                            "textContent": "Uncommon",
                            "html": "Uncommon"
                        }
                    },
                    {
                        "type": "uncommon",
                        "textContent": "uveitis",
                        "html": "uveitis",
                        "frequency": "uncommon",
                        "specificity": {
                            "textContent": "Uncommon",
                            "html": "Uncommon"
                        }
                    },
                    {
                        "type": "uncommon",
                        "textContent": "vomiting",
                        "html": "vomiting",
                        "frequency": "uncommon",
                        "specificity": {
                            "textContent": "Uncommon",
                            "html": "Uncommon"
                        }
                    }
                ],
                "rare": [
                    {
                        "type": "rare",
                        "textContent": "Atypical femoral fractures with long-term use",
                        "html": "Atypical femoral fractures with long-term use",
                        "frequency": "rare",
                        "specificity": {
                            "textContent": "Rare",
                            "html": "Rare"
                        }
                    },
                    {
                        "type": "rare",
                        "textContent": "fever (on initiation)",
                        "html": "fever (on initiation)",
                        "frequency": "rare",
                        "specificity": {
                            "textContent": "Rare",
                            "html": "Rare"
                        }
                    },
                    {
                        "type": "rare",
                        "textContent": "hypocalcaemia",
                        "html": "hypocalcaemia",
                        "frequency": "rare",
                        "specificity": {
                            "textContent": "Rare",
                            "html": "Rare"
                        }
                    },
                    {
                        "type": "rare",
                        "textContent": "osteonecrosis of the jaw",
                        "html": "osteonecrosis of the jaw",
                        "frequency": "rare",
                        "specificity": {
                            "textContent": "Rare",
                            "html": "Rare"
                        }
                    },
                    {
                        "type": "rare",
                        "textContent": "photosensitivity",
                        "html": "photosensitivity",
                        "frequency": "rare",
                        "specificity": {
                            "textContent": "Rare",
                            "html": "Rare"
                        }
                    },
                    {
                        "type": "rare",
                        "textContent": "severe skin reactions",
                        "html": "severe skin reactions",
                        "frequency": "rare",
                        "specificity": {
                            "textContent": "Rare",
                            "html": "Rare"
                        }
                    },
                    {
                        "type": "rare",
                        "textContent": "Stevens-Johnson syndrome",
                        "html": "Stevens-Johnson syndrome",
                        "frequency": "rare",
                        "specificity": {
                            "textContent": "Rare",
                            "html": "Rare"
                        }
                    },
                    {
                        "type": "rare",
                        "textContent": "toxic epidermal necrolysis",
                        "html": "toxic epidermal necrolysis",
                        "frequency": "rare",
                        "specificity": {
                            "textContent": "Rare",
                            "html": "Rare"
                        }
                    }
                ]
            }
        },
        "advice": [
            {
                "type": "advice",
                "title": "Oesophageal reactions",
                "textContent": "Severe oesophageal reactions (oesophagitis, oesophageal ulcers, oesophageal stricture and oesophageal erosions) have been reported; patients should be advised to stop taking the tablets and to seek medical attention if they develop symptoms of oesophageal irritation such as dysphagia, new or worsening heartburn, pain on swallowing or retrosternal pain.",
                "html": "<p>Severe oesophageal reactions (oesophagitis, oesophageal ulcers, oesophageal stricture and oesophageal erosions) have been reported; patients should be advised to stop taking the tablets and to seek medical attention if they develop symptoms of oesophageal irritation such as dysphagia, new or worsening heartburn, pain on swallowing or retrosternal pain.</p>"
            }
        ]
    },
    "pregnancy": {
        "generalInformation": [
            {
                "type": "generalInformation",
                "textContent": "Avoid.",
                "html": "<p>Avoid.</p>"
            }
        ]
    },
    "breastFeeding": {
        "generalInformation": [
            {
                "type": "generalInformation",
                "textContent": "Manufacturer advises avoid&#8212;no information available.",
                "html": "<p>Manufacturer advises avoid&#8212;no information available.</p>"
            }
        ]
    },
    "renalImpairment": {
        "generalInformation": [
            {
                "type": "generalInformation",
                "textContent": "Avoid if eGFR less than 35 mL/minute/1.73 m2.",
                "html": "<p>Avoid if eGFR less than 35&#8239;mL/minute/1.73&#8239;m<sup>2</sup>.</p>"
            }
        ]
    },
    "monitoringRequirements": {
        "patientParameters": [
            {
                "type": "patientParameters",
                "textContent": "Correct disturbances of calcium and mineral metabolism (e.g. vitamin-D deficiency, hypocalcaemia) before starting treatment. Monitor serum-calcium concentration during treatment.",
                "html": "<p>Correct disturbances of calcium and mineral metabolism (e.g. vitamin-D deficiency, hypocalcaemia) before starting treatment. Monitor serum-calcium concentration during treatment.</p>"
            }
        ]
    },
    "directionsForAdministration": {
        "directionsForAdministration": [
            {
                "type": "directionsForAdministration",
                "textContent": "Tablets should be swallowed whole and oral solution should be swallowed as a single 100 mL dose. Doses should be taken with plenty of water while sitting or standing, on an empty stomach at least 30 minutes before breakfast (or another oral medicine); patient should stand or sit upright for at least 30 minutes after administration.",
                "html": "<p>Tablets should be swallowed whole and oral solution should be swallowed as a single 100&#8239;mL dose. Doses should be taken with plenty of water while sitting or standing, on an empty stomach at least 30 minutes before breakfast (or another oral medicine); patient should stand or sit upright for at least 30 minutes after administration.</p>"
            }
        ]
    },
    "patientAndCarerAdvice": {
        "generalPatientAdvice": [
            {
                "type": "generalPatientAdvice",
                "textContent": "Patients or their carers should be given advice on how to administer alendronic acid tablets and oral solution.",
                "html": "<p>Patients or their carers should be given advice on how to administer alendronic acid tablets and oral solution.</p>"
            },
            {
                "type": "generalPatientAdvice",
                "title": "Oesophageal reactions",
                "textContent": "Patients (or their carers) should be advised to stop taking alendronic acid and to seek medical attention if they develop symptoms of oesophageal irritation such as dysphagia, new or worsening heartburn, pain on swallowing or retrosternal pain.",
                "html": "<p>Patients (or their carers) should be advised to stop taking alendronic acid and to seek medical attention if they develop symptoms of oesophageal irritation such as dysphagia, new or worsening heartburn, pain on swallowing or retrosternal pain.</p>"
            }
        ]
    },
    "nationalFunding": {
        "niceTechnologyAppraisals": [
            {
                "type": "niceTechnologyAppraisals",
                "references": [
                    {
                        "id": "http://www.nice.org.uk/TA160",
                        "label": "www.nice.org.uk/TA160"
                    }
                ],
                "fundingIdentifier": "NICE TA160",
                "textContent": "Alendronate, etidronate, risedronate, raloxifene and strontium ranelate for the primary prevention of osteoporotic fragility fractures in postmenopausal women (October 2008) Alendronate is recommended as a treatment option for the primary prevention of osteoporotic fractures in the following susceptible postmenopausal women: Women over 70 years who have an independent risk factor for fracture (parental history of hip fracture, alcohol intake of 4 or more units per day, or rheumatoid arthritis) or an indicator of low bone mineral density (body mass index under 22 kg/m2, ankylosing spondylitis, Crohn&#8217;s disease, prolonged immobility, untreated premature menopause, or rheumatoid arthritis) and confirmed osteoporosis. Women aged 65&#8211;69 years who have an independent risk factor for fracture and confirmed osteoporosis. Women under 65 years who have an independent risk factor for fracture and at least one additional indicator of low bone mineral density and confirmed osteoporosis.\n\nwww.nice.org.uk/TA160",
                "html": "<p outputclass=\"title\">Alendronate, etidronate, risedronate, raloxifene and strontium ranelate for the primary prevention of osteoporotic fragility fractures in postmenopausal women (October 2008)</p> <p> <b>Alendronate</b> is recommended as a treatment option for the primary prevention of osteoporotic fractures in the following susceptible postmenopausal women:</p> <ul> <li>Women over 70 years who have an independent risk factor for fracture (parental history of hip fracture, alcohol intake of 4 or more units per day, or rheumatoid arthritis) <i>or</i> an indicator of low bone mineral density (body mass index under 22&#8239;kg/m<sup>2</sup>, ankylosing spondylitis, Crohn&#8217;s disease, prolonged immobility, untreated premature menopause, or rheumatoid arthritis) <b>and</b> confirmed osteoporosis.</li> <li>Women aged 65&#8211;69 years who have an independent risk factor for fracture and confirmed osteoporosis.</li> <li>Women under 65 years who have an independent risk factor for fracture and at least one additional indicator of low bone mineral density and confirmed osteoporosis.</li> </ul><xref format=\"html\" href=\"http://www.nice.org.uk/TA160\">www.nice.org.uk/TA160</xref>"
            },
            {
                "type": "niceTechnologyAppraisals",
                "references": [
                    {
                        "id": "http://www.nice.org.uk/TA161",
                        "label": "www.nice.org.uk/TA161"
                    }
                ],
                "fundingIdentifier": "NICE TA161",
                "textContent": "Alendronate, etidronate, risedronate, raloxifene, strontium ranelate, and teriparatide for the secondary prevention of osteoporotic fragility fractures in postmenopausal women (October 2008) This guideline recommends treatment options for the secondary prevention of osteoporotic fractures in postmenopausal women with confirmed osteoporosis who have also sustained a clinically apparent osteoporotic fracture. Alendronate is recommended as a treatment option for the secondary prevention of osteoporotic fractures in susceptible postmenupausal women.\n\nwww.nice.org.uk/TA161",
                "html": "<p outputclass=\"title\">Alendronate, etidronate, risedronate, raloxifene, strontium ranelate, and teriparatide for the secondary prevention of osteoporotic fragility fractures in postmenopausal women (October 2008)</p> <p>This guideline recommends treatment options for the secondary prevention of osteoporotic fractures in postmenopausal women with confirmed osteoporosis who have also sustained a clinically apparent osteoporotic fracture.</p> <p> <b>Alendronate</b> is recommended as a treatment option for the secondary prevention of osteoporotic fractures in susceptible postmenupausal women.</p><xref format=\"html\" href=\"http://www.nice.org.uk/TA161\">www.nice.org.uk/TA161</xref>"
            }
        ]
    },
    "medicinalForms": {
        "licensingVariationStatement": [
            {
                "type": "licensingVariationStatement",
                "textContent": "There can be variation in the licensing of different medicines containing the same drug.",
                "html": "<p>There can be variation in the licensing of different medicines containing the same drug.</p>"
            }
        ],
        "availableForms": {
            "before": "Forms available from special-order manufacturers include",
            "forms": [
                "oral solution"
            ]
        }
    },
    "children": {
        "medicinalForm": [
            {
                "id": "PHP75004",
                "label": "Tablet",
                "type": "medicinalForm"
            },
            {
                "id": "PHP75020",
                "label": "Oral solution",
                "type": "medicinalForm"
            }
        ]
    },
    "backlinks": {
        "drug": [
            {
                "id": "PHP85566",
                "label": "ALENDRONIC ACID WITH COLECALCIFEROL",
                "type": "drug"
            }
        ],
        "drugClassifications": [
            {
                "id": "PHP106980",
                "label": "Drug classifications",
                "type": "drugClassifications"
            }
        ],
        "treatmentSummary": [
            {
                "id": "PHP78314",
                "label": "Bone metabolism",
                "type": "treatmentSummary"
            }
        ]
    },
    "links": {
        "interaction": [
            {
                "id": "bnf_int_459",
                "label": "Alendronic Acid",
                "type": "interaction"
            }
        ],
        "drugClass": [
            {
                "id": "PHP34620",
                "label": "BISPHOSPHONATES",
                "type": "drugClass"
            }
        ],
        "#drugs": [
            {
                "id": "drugs",
                "label": "Drugs",
                "type": "#drugs"
            }
        ],
        "medicinalForm": [
            {
                "id": "PHP75004",
                "label": "Tablet",
                "type": "medicinalForm"
            },
            {
                "id": "PHP75020",
                "label": "Oral solution",
                "type": "medicinalForm"
            }
        ]
    }
}